‘Rogue Antibodies’ Involved in Severe COVID-19 Blood Clots
Circulating antiphospholipid antibodies which target a person’s own organs and systems, can also be activated in response to viral infections and may play a role with COVID-19 blood clots.
Circulating antiphospholipid antibodies which target a person’s own organs and systems, can also be activated in response to viral infections and may play a role with COVID-19 blood clots.
Only a small percentage of hospitalized patients with acute pulmonary embolism are discharged home from the emergency department, according to new research in the Academic Emergency Medicine journal.
Mirza Teletovic, a forward for the NBA's Milwaukee Bucks, has been diagnosed with pulmonary embolism in both lungs and will be out of action as a result.
About one of every six patients hospitalized for a first episode of syncope has a pulmonary embolism, according to a NEJM published study.
Read MoreInsmed Incorporated has disclosed a licensing agreement with AstraZeneca for the global rights to AZD7986, a new oral drug that may help treat rare pulmonary diseases.
Read MoreWhile ICU utilization was not associated with significant differences in hospital mortality, it was associated with more invasive procedures and higher costs, a JAMA Internal Medicine study reports.
Read MoreAccording to an article by Slate, a Tesla Model X successfully self-piloted itself to a Missouri hospital after its 37-year-old owner suffered a pulmonary embolism.
Read MoreThe oral direct factor Xa inhibitor, edoxaban, may be as effective as warfarin for the prevention of symptomatic recurrent venous thromboembolism (VTE).
Read MoreExtended treatment with the oral anticoagulant edoxaban prevented recurrent venous thromboembolism and led to fewer major bleeding events than warfarin.
Read MoreA retrospective study suggests that there is insufficient follow-up in pulmonary embolism patients who have a high risk of developing chronic thromboembolic pulmonary hypertension.
Read MoreAlmost one-in-six pulmonary embolism patients are treated with inferior vena caval (IVC) filters, despite uncertain benefits.
Read MoreThe use of inferior vena caval filters (IVCFs) for pulmonary embolism (PE) increased from 1999 through 2010, according to research.
Read MoreAccording to Yale researchers, patients being screened for deep vein thrombosis (DVT) using an ultrasound have a rare but serious risk of pulmonary embolism.
Read MoreIn a new evidence-based guideline, experts from the American College of Chest Physicians provide 53 updated recommendations for appropriate treatment of patients with VTE.
Read MoreDabigatran (Pradaxa) has received FDA approval for prevention of deep vein thrombosis and pulmonary embolism in patients undergoing hip replacement surgery.
Read More